Zoledronic acid - Novartis
At a glance
- Drug Originator Novartis
- Drug Licenced by Asahi Kasei Pharma Corp; Nippon Kayaku; SciClone Pharmaceuticals; TCM Biotech International
- Drug Class Antineoplastics; Bisphosphonates; Calcium regulators; Imidazoles; Osteoporosis therapies; Small molecules
- Mechanism of Action Bone resorption factor inhibitors; Geranyltranstransferase inhibitors; Osteoclast inhibitors
- USA Patent Applicants NOVARTIS; SANDOZ
- USA Patents 6
- NDAs 2
- International Patents 39
- Patent Applications 8,215

Disclaimer